Inderes’s Q3 sales came in line with our estimates, while EBITA was 4% above our estimate thanks to lower slightly lower personnel costs. However, the soft spot of the report is the slower-than-expected development of international sales (read Sweden). Also the number of research contracts stayed flat q/q and was slightly below our estimate, indicating our Q4 sales estimate of 9% may be slightly optimistic.
LÄS MER
